Lincoln (LINCOLN) | Stock Overview & Key Data
Lincoln Performance Comparison
Stock Range
Today's Range
Low: ₹543.00
High: ₹554.25
on August 13, 2025
52 Week Range
Low: ₹499.00
High: ₹979.50
on March 3, 2025
on December 9, 2024
All-Time High: ₹979.50 on December 9, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR11.2B
EPS
41.11
P/E Ratio (TTM)
13.62
Forward P/E
N/A
P/B Ratio
1.67
PEG Ratio
-1.16
Div. Yield
0.31%
ROE
13.02%
Beta
0.204
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
52.34%
Operating Margin
13.97%
Profit Margin
13.21%
Returns and Earnings
Return on Assets (TTM)
7.40%
Return on Equity (TTM)
13.02%
EBITDA
INR1.2B
Net Income (TTM)
INR823.5M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR311.15
Quarterly Revenue Growth (YoY)
18.00%
Quarterly Earnings Growth (YoY)
-37.80%
Dividend Information
Last 12-Month Dividend
₹1.80
Current Dividend Yield
0.31%
3-Year Average Dividend Yield
0.35%
3-Year Average Annual Dividend
₹1.60
3-Year Total Dividends
₹4.80
Ex-Dividend Date
September 13, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lincoln LINCOLN | 11.24B Small-cap | 2.25% | -0.22% | -4.47% | -17.75% | -36.21% | -16.77% | 86.65% | 122.70% |
| Sun Pharmaceutical SUNPHARMA | 3.81T Large-cap | -0.61% | -3.59% | -3.80% | -4.23% | -14.17% | -7.71% | 78.44% | 202.13% |
| Divi's Laboratories DIVISLAB | 1.59T Large-cap | -6.99% | -12.06% | 0.32% | -0.15% | -1.84% | 28.64% | 61.27% | 83.57% |
| Sun Pharma Advanced SPARC | 46.41B Small-cap | -2.63% | -11.98% | -4.53% | -3.07% | -29.29% | -33.23% | -41.02% | -21.77% |
| Aarti Drugs AARTIDRUGS | 44.67B Small-cap | 1.65% | 1.81% | 14.25% | 24.49% | 7.45% | -1.48% | 9.59% | -37.52% |
| Sequent Scientific SEQUENT | 43.53B Small-cap | -2.62% | -6.11% | 2.95% | 14.81% | -5.65% | 23.40% | 60.75% | 35.04% |
Ownership & Short Interest
Insider Ownership
55.08%
Institutional Ownership
0.93%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
573K
Average 90-Day Volume
214K
Lincoln Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Lincoln would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LINCOLN's 52-week high and low?
- In the last 52 weeks, Lincoln reached a high of ₹979.50 (on December 9, 2024) and a low of ₹499.00 (on March 3, 2025).
- What is the market cap and P/E ratio for LINCOLN?
- Curious about Lincoln's size and valuation? Its market capitalization stands at 11.24B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.62, and the forward P/E (looking ahead) is N/A.
- Does LINCOLN pay dividends? If so, what's the yield?
- Yes, Lincoln is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.31%, and the company has paid an average of ₹1.60 per share annually over the past 3 years.
- Who are Lincoln's main competitors or similar companies to consider before investing?
When looking at Lincoln, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.81T Healthcare Drug Manufacturers - Specialty & Generic -7.71% 78.44% Divi's Laboratories
DIVISLAB1.59T Healthcare Drug Manufacturers - Specialty & Generic 28.64% 61.27% Sun Pharma Advanced
SPARC46.41B Healthcare Drug Manufacturers - Specialty & Generic -33.23% -41.02% Aarti Drugs
AARTIDRUGS44.67B Healthcare Drug Manufacturers - Specialty & Generic -1.48% 9.59% Sequent Scientific
SEQUENT43.53B Healthcare Drug Manufacturers - Specialty & Generic 23.40% 60.75% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lincoln Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Lincoln's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.02%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 52.34%.
- What is the recent revenue and earnings growth for LINCOLN?
- Looking at Lincoln's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.00%, and quarterly earnings saw a YoY growth of -37.80%.
- How much of LINCOLN stock is held by insiders and institutions?
- Wondering who owns Lincoln stock? Company insiders (like executives and directors) hold about 55.08% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.93%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.